NIH-funded research NIH-funded research

New injectable medical devices for better disease management

Official title: Minimally Invasive and Versatile Next-Generation Implantable Medical Devices: A Leap Towards Precision Therapies and Medicine

Funded at University of Florida · NIH-10909550 · Data updated 2026-11-12

This study is working on new tiny medical devices that can be injected into the body without surgery, making them safer and easier to use for people with nerve-related conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 9, 2024
Project endSeptember 8, 2027
Funding year2024
Award (this year)$1,267,914
NIH project number1DP2EB037188-01
Project IDNIH-10909550 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with conditions that could benefit from advanced implantable devices, particularly those affecting the nervous system.

Less likely to help

Patients with conditions that do not require implantable devices or those who are not candidates for surgical interventions may not benefit from this research.

What this research studies

This research focuses on developing next-generation implantable medical devices (IMDs) that are minimally invasive and versatile. The project aims to create wireless, battery-free microchips that can be injected anywhere in the body, allowing for better interfacing with nerve cells and reducing the risks associated with traditional devices. By utilizing innovative techniques such as energy harvesting and advanced microfabrication, these devices will be designed to improve patient outcomes while minimizing tissue damage during placement. The research will involve collaboration with medical professionals to ensure the devices meet clinical needs.

Why it matters

Potential benefit: If successful, this research could lead to more effective and less invasive treatments for a variety of diseases.

How similar studies have gone: Other research has shown promise in developing advanced implantable devices, but this approach is particularly novel due to its focus on wireless, injectable technology.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Khalifa, Adam — University of Florida
  • Study coordinator: Khalifa, Adam

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.